FibroGen
FibroGen Industry Presentation
FibroGen accelerates the delivery of innovative treatments that operate at the cutting edge of cancer research. Our teams have identified and are developing potential first-in-class medicines for the treatment of life-threatening conditions such as metastatic pancreatic cancer, locally advanced pancreatic cancer (LAPC), and chemotherapy-induced anemia (CIA). We are keenly focused on leveraging the body’s natural pathways to treat cancer and its related conditions.
Bassem Elmankabadi, MD, ABWS
Executive Medical Director, Clinical Development (Fibrosis/Oncology)
FibroGen